Total Funding
78
46
Total FundingSeries A raised
Growth Score
-12 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
42071
Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments.
- Patrick Pumputis: Co-Founder and Scientific AdvisorPast Role: Acorn Biolabs, Co-Founder and CSO
- Drew Taylor: Chief Executive Officer and Co-FounderPast Role: Mount Sinai Health System, BioEngineering of Skeletal Tissues Team
About the Company
Acorn Biolabs is a healthcare technology company that provides access to the future of cell-based medicine through a non-invasive, follicle-based cell collection and cryopreservation service. Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments. Acorn Biolabs' services are available to
consumers directly through at-home and in-clinic collections and are available across Canada through a network of clinic and pharmacy partners.
